GPT Healthcare (GPTHEALTH.NS) Stock Price

GPT Healthcare Price

CLOSED
154.98INR-2.30 (-1.47 %)
Market closed

Over the last 4 years GPT Healthcare grew revenue by 13.8% annually, reaching 4.07 B INR. Earnings per share have grown at 24.0% per year over the last 4 years. For GPT Healthcare, the net margin of 12.3% is up versus 8.7% a few years ago. At today's price the dividend yield works out to roughly 1.61%. The payout ratio is around 41% of earnings. The consensus 12-month price target for GPT Healthcare is 138.72 INR, about 10.5% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus. The stock trades about 35% above its 52-week low.

GPT Healthcare stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of GPT Healthcare over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how GPT Healthcare stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing GPT Healthcare's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

GPT Healthcare Stock Price History
DateGPT Healthcare Price
8/13/2026154.98 INR
8/12/2026157.28 INR
8/10/2026157.14 INR
8/7/2026159.44 INR
8/6/2026165.03 INR
8/5/2026164.70 INR
8/4/2026162.16 INR
7/31/2026170.49 INR
7/30/2026164.25 INR
7/28/2026166.13 INR
7/24/2026159.64 INR
7/23/2026156.75 INR
7/22/2026151.85 INR
7/20/2026149.05 INR
7/17/2026152.54 INR
7/15/2026152.21 INR
7/14/2026154.10 INR
7/13/2026156.80 INR
7/10/2026158.11 INR
7/9/2026158.32 INR
7/8/2026150.58 INR
7/7/2026156.74 INR
7/3/2026158.81 INR
7/2/2026156.47 INR
7/1/2026150.06 INR
6/30/2026148.51 INR
6/29/2026146.68 INR
6/25/2026147.51 INR
6/24/2026149.92 INR
6/23/2026148.63 INR
6/22/2026149.98 INR
6/19/2026147.82 INR
6/18/2026146.76 INR
6/17/2026144.91 INR
6/16/2026147.36 INR
6/15/2026149.14 INR
6/12/2026148.17 INR
6/11/2026144.51 INR
6/10/2026148.25 INR
6/9/2026149.98 INR
6/8/2026147.20 INR
6/5/2026149.64 INR
6/4/2026152.43 INR
6/3/2026151.44 INR
6/2/2026151.41 INR
6/1/2026143.13 INR
5/29/2026142.40 INR
5/28/2026139.92 INR
5/27/2026139.92 INR
5/26/2026139.12 INR
5/25/2026139.26 INR
5/22/2026139.99 INR
5/21/2026140.65 INR
5/20/2026141.91 INR
5/19/2026142.84 INR
5/18/2026138.76 INR
5/15/2026141.55 INR
5/14/2026140.48 INR
5/13/2026141.78 INR
5/12/2026141.85 INR
5/11/2026142.39 INR
5/8/2026144.12 INR
5/7/2026142.47 INR
5/6/2026140.79 INR
5/5/2026142.93 INR
5/4/2026141.45 INR
4/30/2026138.43 INR
4/29/2026135.50 INR
4/28/2026138.08 INR
4/27/2026136.10 INR
4/24/2026136.31 INR
4/23/2026134.31 INR
4/22/2026135.35 INR
4/21/2026135.43 INR
4/20/2026136.84 INR
4/17/2026137.43 INR
4/16/2026135.89 INR
4/15/2026135.23 INR
4/13/2026137.63 INR
4/10/2026139.98 INR
4/9/2026136.95 INR
4/8/2026134.71 INR
4/7/2026130.88 INR
4/6/2026125.83 INR
4/2/2026123.32 INR
4/1/2026120.00 INR
3/30/2026115.00 INR
3/27/2026115.55 INR
3/25/2026122.00 INR
3/24/2026119.02 INR
3/23/2026119.00 INR
3/20/2026120.72 INR
3/19/2026123.76 INR
3/18/2026124.50 INR
3/17/2026121.00 INR
3/16/2026123.00 INR
3/13/2026124.57 INR
3/12/2026127.20 INR
3/11/2026125.45 INR
3/10/2026122.50 INR
3/9/2026121.88 INR
3/6/2026125.06 INR
3/5/2026122.00 INR
3/4/2026120.80 INR
3/2/2026125.20 INR
2/27/2026126.50 INR
2/26/2026127.55 INR
2/25/2026124.70 INR
2/24/2026122.45 INR
2/23/2026124.90 INR
2/20/2026127.01 INR
2/19/2026127.15 INR
2/18/2026128.00 INR
2/17/2026129.35 INR
2/16/2026129.45 INR
2/13/2026128.45 INR
2/12/2026129.00 INR
2/11/2026129.70 INR
2/10/2026129.90 INR
2/9/2026128.60 INR
2/6/2026129.05 INR
2/5/2026127.11 INR
2/4/2026129.39 INR
2/3/2026127.50 INR
2/2/2026128.15 INR
2/1/2026129.00 INR
1/30/2026129.85 INR
1/29/2026126.60 INR
1/28/2026127.95 INR
1/27/2026127.00 INR
1/23/2026129.63 INR
1/22/2026129.01 INR
1/21/2026131.10 INR
1/20/2026131.70 INR
1/19/2026135.41 INR
1/16/2026134.80 INR
1/14/2026134.00 INR
1/13/2026135.48 INR
1/12/2026135.35 INR
1/9/2026135.45 INR
1/8/2026136.50 INR
1/7/2026140.05 INR
1/6/2026141.99 INR
1/5/2026138.70 INR
1/2/2026142.05 INR
1/1/2026140.05 INR
12/31/2025140.99 INR
12/30/2025141.00 INR
12/29/2025143.30 INR
12/26/2025136.52 INR
12/24/2025137.30 INR
12/23/2025137.10 INR
12/22/2025138.00 INR
12/19/2025136.94 INR
12/18/2025136.00 INR
12/17/2025139.87 INR
12/16/2025141.40 INR
12/15/2025141.00 INR
12/12/2025140.40 INR
12/11/2025140.05 INR
12/10/2025139.25 INR
12/9/2025137.80 INR
12/8/2025140.25 INR
12/5/2025142.90 INR
12/4/2025141.17 INR
12/3/2025139.15 INR
12/2/2025138.20 INR
12/1/2025139.76 INR
11/28/2025142.00 INR
11/27/2025144.30 INR
11/26/2025141.70 INR
11/25/2025142.50 INR
11/24/2025141.00 INR
11/21/2025144.39 INR
11/20/2025143.60 INR
11/19/2025146.30 INR
11/18/2025146.80 INR
11/17/2025147.60 INR
11/14/2025143.99 INR
11/13/2025143.22 INR
11/12/2025142.15 INR
11/11/2025143.50 INR
11/10/2025143.00 INR
11/7/2025148.98 INR
11/6/2025146.40 INR
11/4/2025149.00 INR
11/3/2025149.47 INR
10/31/2025148.95 INR
10/30/2025150.21 INR
10/29/2025150.49 INR
10/28/2025151.28 INR
10/27/2025151.72 INR
10/24/2025148.50 INR
10/23/2025149.10 INR
10/21/2025150.80 INR
10/20/2025149.24 INR
10/17/2025147.56 INR
10/16/2025146.80 INR
10/15/2025149.00 INR
10/14/2025147.35 INR
10/13/2025146.90 INR
10/10/2025149.00 INR
10/9/2025149.15 INR
10/8/2025149.00 INR
10/7/2025150.49 INR
10/6/2025152.05 INR
10/3/2025148.00 INR
10/1/2025147.60 INR
9/30/2025148.00 INR
9/29/2025147.79 INR
9/26/2025148.95 INR
9/25/2025147.00 INR
9/24/2025149.50 INR
9/23/2025149.75 INR
9/22/2025150.82 INR
9/19/2025150.00 INR
9/18/2025153.48 INR
9/17/2025153.00 INR
9/16/2025153.75 INR
9/15/2025152.70 INR
9/12/2025152.96 INR
9/11/2025154.00 INR
9/10/2025155.67 INR
9/9/2025156.00 INR
9/8/2025155.00 INR
9/5/2025153.41 INR
9/4/2025154.70 INR
9/3/2025153.00 INR
9/2/2025148.55 INR
9/1/2025148.69 INR
8/29/2025148.08 INR
8/28/2025148.15 INR
8/26/2025151.50 INR
8/25/2025154.50 INR
8/22/2025157.45 INR
8/21/2025159.48 INR
8/20/2025158.75 INR
8/19/2025160.50 INR
8/18/2025159.00 INR
Access this data via the Eulerpool API
Get Free API Key

GPT Healthcare Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2021
2.43 B INR
367.62 M INR
210.93 M INR
Jan 1, 2022
3.37 B INR
607.70 M INR
416.63 M INR
Jan 1, 2023
3.61 B INR
604.92 M INR
390.08 M INR
Jan 1, 2024
4.00 B INR
709.65 M INR
477.69 M INR
Jan 1, 2025
4.07 B INR
661.75 M INR
499.22 M INR
Jan 1, 2026 (e)
4.68 B INR
809.81 M INR
377.43 M INR
Jan 1, 2027 (e)
5.58 B INR
963.86 M INR
631.79 M INR
Jan 1, 2028 (e)
6.44 B INR
1.11 B INR
820.50 M INR

GPT Healthcare Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 14, 2026, 12:03 PM
 
REVENUEB INR
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEB INR
EBITB INR
EBIT MARGIN%
NET INCOMEM INR
NET INCOME GROWTH%
DIV.INR
DIV. GROWTH%
SHARESM
202120222023202420252026e2027e2028e
2.433.373.614.004.074.685.586.44
–39.026.9910.831.7215.0919.0215.59
76.3974.1078.9879.2880.6480.6480.6480.64
1.852.502.853.173.283.784.505.20
0.370.610.600.710.660.810.961.11
15.1217.9916.7317.7216.2417.2717.2717.29
210.00416.00390.00477.00499.00377.00631.00820.00
–98.10-6.2522.314.61-24.4567.3729.95
–––4.005.002.502.502.50
––––25.00-50.00––
82.0582.0582.0580.1082.0582.0582.0582.05
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales GPT Healthcare generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue GPT Healthcare retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare GPT Healthcare's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares GPT Healthcare has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against GPT Healthcare's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

GPT Healthcare stock margins

The GPT Healthcare margin analysis displays the gross margin, EBIT margin, as well as the profit margin of GPT Healthcare. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for GPT Healthcare.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2021
76.41 %
15.14 %
8.69 %
Jan 1, 2022
74.10 %
18.01 %
12.35 %
Jan 1, 2023
78.99 %
16.76 %
10.80 %
Jan 1, 2024
79.27 %
17.73 %
11.94 %
Jan 1, 2025
80.64 %
16.26 %
12.26 %
Jan 1, 2026 (e)
80.64 %
17.29 %
8.06 %
Jan 1, 2027 (e)
80.64 %
17.29 %
11.33 %
Jan 1, 2028 (e)
80.64 %
17.29 %
12.73 %

GPT Healthcare Stock Revenue, EBIT, Earnings per Share

The GPT Healthcare earnings per share therefore indicates how much revenue GPT Healthcare has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2021
29.58 INR
4.48 INR
2.57 INR
Jan 1, 2022
41.12 INR
7.41 INR
5.08 INR
Jan 1, 2023
44.00 INR
7.37 INR
4.75 INR
Jan 1, 2024
49.96 INR
8.86 INR
5.96 INR
Jan 1, 2025
49.61 INR
8.06 INR
6.08 INR
Jan 1, 2026 (e)
57.09 INR
9.87 INR
4.60 INR
Jan 1, 2027 (e)
67.95 INR
11.75 INR
7.70 INR
Jan 1, 2028 (e)
78.54 INR
13.58 INR
10.00 INR

GPT Healthcare business model & stock analysis

GPT Healthcare Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

GPT Healthcare historical P/E ratio, EBIT multiple, and P/S ratio

GPT Healthcare annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

GPT Healthcare shares outstanding

The number of shares of GPT Healthcare was 82.05 M in 2025. This indicates how many shares GPT Healthcare is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2021
82.05 M Stocks
Jan 1, 2022
82.05 M Stocks
Jan 1, 2023
82.05 M Stocks
Jan 1, 2024
80.10 M Stocks
Jan 1, 2025
82.05 M Stocks
Jan 1, 2026 (e)
82.05 M Stocks
Jan 1, 2027 (e)
82.05 M Stocks
Jan 1, 2028 (e)
82.05 M Stocks

GPT Healthcare Dividend History

3 years of dividend payments

YearAnnual DividendYoY ChangePayments
20261.50INRYTD—1×
Jul 30, 20261.50INR↑ 50.0%1/1
20252.50INR↓ 28.6%2×
Jul 29, 20251.50INR↑ 50.0%1/2
Nov 14, 20251.00INR↓ 33.3%2/2
20243.50INR—3×

GPT Healthcare dividend history and estimates

In 2025, GPT Healthcare paid a dividend amounting to 2.50 INR. Dividend means that GPT Healthcare distributes a portion of its profits to its owners.

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2024 (e)
3.50 INR
0.50 INR
Jan 1, 2025 (e)
2.50 INR
2.50 INR
Jan 1, 2026
2.50 INR
0.00 INR
Jan 1, 2027 (e)
0.00 INR
2.50 INR
Jan 1, 2028 (e)
0.00 INR
2.50 INR

GPT Healthcare dividend payout ratio

In 2025, GPT Healthcare had a payout ratio of 41.09%. The payout ratio indicates the percentage of the company's profits that GPT Healthcare distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2021
49.89 %
Jan 1, 2022
49.89 %
Jan 1, 2023
49.89 %
Jan 1, 2024
58.69 %
Jan 1, 2025
41.09 %
Jan 1, 2026 (e)
54.35 %
Jan 1, 2027 (e)
32.47 %
Jan 1, 2028 (e)
25.00 %

Current GPT Healthcare forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
80.00 % (4)
Hold
20.00 % (1)
Sell
0.00 % (0)
12M Price Target
138.72
Last Price
160.51
Currency
INR
12M Return Potential
-13.58 %
LTM Return
0 %

GPT Healthcare shareholder structure

% Name
65.57550%
GPT Sons Pvt. Ltd.
GPT Sons Pvt. Ltd.
4.71981%
Bandhan Asset Management Company Limited
Bandhan Asset Management Company Limited
2.68129%
Ocean Dial Asset Management, Ltd.
Ocean Dial Asset Management, Ltd.
0.04776%
American Century Investment Management, Inc.
American Century Investment Management, Inc.
0.00107%
Motilal Oswal Asset Management Company Ltd.
Motilal Oswal Asset Management Company Ltd.
0.00037%
Tantia (Vinita)
Tantia (Vinita)

GPT Healthcare Beneficial Ownership Filings (SEC 13D/G)

Free Float
32.8%
Float Shares
-
Shares Outstanding
-

GPT Healthcare Executives and Management Board

11 members · avg. age 63 · 27 % women

OT

Dr. Om Tantia (68)

Managing Director, Executive Director · since 2005

29.02 M INR

Management

KT

Mrs. Kriti Tantia

Chief Financial Officer

11.89 M INR
AS

Mr. Ankur Sharma

Compliance Officer, Company Secretary

1.25 M INR

Board of Directors

AT

Mr. Anurag Tantia (38)

Whole Time Director · since 2011

15.96 M INR
GG

Dr. Ghanshyam Goyal (66)

Non-Executive Non-Independent Director

14.39 M INR
AT

Dr. Aruna Tantia (68)

Non-Executive Non-Independent Director

7.64 M INR
KK

Mr. Kashi Khandelwal (75)

Non-Executive Lead Independent Director

472,000.00 INR
DP

Mr. Deepak Pramanik (61)

Non-Executive Independent Director

424,800.00 INR
AV

Mr. Amrendra Verma (73)

Non-Executive Independent Director

424,800.00 INR

Frequently asked questions about GPT Healthcare

Analysts currently set an average price target of 138.72 INR for the GPT Healthcare stock (median: 138.72 INR), implying -13.6 % versus the latest price. The consensus is based on 5 analyst ratings.

GPT Healthcare Analyst Price Targets 2026

5 analysts currently rate the GPT Healthcare stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect GPT Healthcare to generate revenue of 4.68 B INR and earnings per share of 4.60 INR.

GPT Healthcare Analyst Price Targets 2026

Converted at the current exchange rate, the GPT Healthcare share trades at 1.41 EUR (154.98 INR).

No history available for GPT Healthcare.

The expected revenue of GPT Healthcare is 4.68 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of GPT Healthcare is 377.43 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of GPT Healthcare is currently 33.69. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the GPT Healthcare stock.

The price-to-sales ratio (P/S) of GPT Healthcare is currently 2.71. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the GPT Healthcare stock.

The Eulerpool Quality Score for GPT Healthcare is 4/10.

The ISIN of GPT Healthcare is INE486R01017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of GPT Healthcare is GPTHEALTH.NS. The ticker symbol is used to trade GPT Healthcare shares on the stock exchange.

Over the past 12 months, GPT Healthcare paid a dividend of 2.50 INR . This corresponds to a dividend yield of about 1.61 %. For the coming 12 months, GPT Healthcare is expected to pay a dividend of 2.50 INR.

The current dividend yield of GPT Healthcare is 1.61 %.

GPT Healthcare pays a dividend, distributed in the months of , , , .

GPT Healthcare paid dividends every year for the past 2 years.

For the upcoming 12 months, dividends amounting to 2.50 INR are expected. This corresponds to a dividend yield of 1.61 %.

GPT Healthcare is assigned to the 'Health' sector.

In the year 2025, GPT Healthcare distributed 1 INR as dividends.

The dividends of GPT Healthcare are distributed in INR.

All fundamentals and in-depth analysis of GPT Healthcare

Our stock analysis for GPT Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of GPT Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

GPT Healthcare Stock
GPT Healthcare Revenue→
GPT Healthcare Stock
GPT Healthcare Net Income→
GPT Healthcare Stock
GPT Healthcare P/E→
GPT Healthcare Stock
GPT Healthcare P/S→
GPT Healthcare Stock
GPT Healthcare EBIT→
GPT Healthcare Stock
GPT Healthcare Dividend→
GPT Healthcare Stock
GPT Healthcare Directors Dealings→
GPT Healthcare Stock
GPT Healthcare Stocks→
GPT Healthcare Stock
GPT Healthcare Market capitalization→
GPT Healthcare Stock
GPT Healthcare Debt→
GPT Healthcare Stock
GPT Healthcare Liabilities→
GPT Healthcare Stock
GPT Healthcare Equity→
GPT Healthcare Stock
GPT Healthcare AAQS→
GPT Healthcare Stock
GPT Healthcare Employees→
GPT Healthcare Stock
GPT Healthcare ROE→
GPT Healthcare Stock
GPT Healthcare ROA→
GPT Healthcare Stock
GPT Healthcare ROCE→
GPT Healthcare Stock
GPT Healthcare News→
GPT Healthcare Stock
GPT Healthcare Analyst Price Targets→

Health Stocks

Grace BreedingGPI SpAGrace Therapeutics,Gossamer BiograceNT AG in LiquidationGoodwill E-Health Info CoGrailGoodRx HoldingsGrand Brilliance Group HoldingsGood Fellow Healthcare HoldingsGranules IndiaGongwin Biopharm Holdings CoAll Stocks A–Z →